metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPA...
Información de la revista
Vol. 29. Núm. S3.
Abstracts of the 2024 Annual Meeting of the ALEH
(diciembre 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S3.
Abstracts of the 2024 Annual Meeting of the ALEH
(diciembre 2024)
Acceso a texto completo
P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPATITIS AND LONG COVID
Visitas
179
Lucas da Silva Lima1, Juliana Maul Cardoso1, Iolanda Raquel Paulo Ferreira1, Luciane Leon Almeida Amado2, Otacilio Moreira Da Cruz3, Wagner Luis Coelho da Costa Nunes Pimentel2, Lia Lewis Laura1, Vanessa Salete De Paula3, Giovana Angelice Paula1, Livia Villar Melo1
1 National Reference Laboratory for Viral Hepatitis, Institute Oswaldo Cruz, Fiocruz Rio de Janeiro, Brasil
2 Technological Development Laboratory, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brasil
3 Molecular Virology and Parasitology Laboratory, Institute Oswaldo Cruz, Oswaldo Cruz Foundation, Rio de Janeiro, Brasil
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S3

Abstracts of the 2024 Annual Meeting of the ALEH

Más datos
Conflict of interest

No

Introduction and Objectives

Long COVID syndrome affects millions of people and is characterized by the permanence of signs and symptoms after 90 days of SARS-CoV-2 infection. MicroRNAs (miRNAs) are small non-coding RNAs that are related to different conditions and can characterize profiles including liver disease. OBJECTIVES: Characterize the serum expression of miRNAs in relation to viral hepatitis B and C and Long COVID.

Patients / Materials and Methods

Serums were obtained from 69 individuals from 4 groups: (i) only Long COVID (n=18); (ii) Viral Hepatitis/Long COVID (n=21); (iii) only Viral Hepatitis (n=10) and (iv) control individuals (n=20). MiRNAs were isolated using a commercial extraction kit and miR-122, miR-143 and miR-223 were evaluated using quantitative real-time PCR. The expression of the examined genes was calculated from the formula RQ = 2-ΔΔCT. Statistical analysis was carried out using GraphPad Prism 9.5.1 software.

Results and Discussion

The upregulation of the miRNAs analyzed was observed in the groups with diseases compared to the control, all with statistical significance (p<0.05). Of the groups with diseases, the Viral Hepatitis/Long COVID group showed the highest expression of all three miRNAs analyzed. For miR-122, the Viral Hepatitis/Long COVID and only Viral Hepatitis groups were up-regulated with mean RQ of 100.38 ± 122.06 and 80.72 ± 173.16, respectively, compared to the control 3.20 ± 8.75 (p<0.05). For miR-143 and mir-223, the highest expression was in the Hepatitis/Long COVID (mean RQ: 316.36 ± 572.96 and 270.45 ± 558.55, respectively) followed by the only Long COVID group (mean RQ: 158.12 ± 262.42 and 115.65 ± 191.30, respectively), both with statistical significance when compared to the control (mean RQ: 4.12 ± 5.37 and 3.78 ± 8.5, respectively).

Conclusions

The presence of disease affects the expression of these miRNAs when compared to healthy individuals. The description of these targets will contribute to the understanding of Long COVID and its association with other diseases.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos